SG
StoneX Group’s Thermo Fisher Scientific TMO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.62M | Sell |
3,983
-21
| -0.5% | -$8.52K | 0.08% | 220 |
|
2025
Q1 | $1.99M | Buy |
4,004
+694
| +21% | +$346K | 0.11% | 175 |
|
2024
Q4 | $1.72M | Buy |
3,310
+512
| +18% | +$267K | 0.09% | 190 |
|
2024
Q3 | $1.73M | Buy |
2,798
+358
| +15% | +$222K | 0.78% | 20 |
|
2024
Q2 | $1.35M | Buy |
2,440
+448
| +22% | +$248K | 0.63% | 31 |
|
2024
Q1 | $1.16M | Buy |
1,992
+240
| +14% | +$140K | 0.6% | 34 |
|
2023
Q4 | $930K | Buy |
1,752
+198
| +13% | +$105K | 0.5% | 42 |
|
2023
Q3 | $787K | Buy |
1,554
+60
| +4% | +$30.4K | 0.44% | 48 |
|
2023
Q2 | $780K | Sell |
1,494
-70
| -4% | -$36.5K | 0.44% | 53 |
|
2023
Q1 | $902K | Buy |
1,564
+234
| +18% | +$135K | 0.54% | 40 |
|
2022
Q4 | $733K | Buy |
+1,330
| New | +$733K | 0.11% | 154 |
|
2022
Q2 | – | Sell |
-1,671
| Closed | -$987K | – | 728 |
|
2022
Q1 | $987K | Buy |
1,671
+465
| +39% | +$275K | 0.09% | 186 |
|
2021
Q4 | $805K | Buy |
1,206
+185
| +18% | +$124K | 0.09% | 207 |
|
2021
Q3 | $584K | Buy |
1,021
+97
| +10% | +$55.5K | 0.08% | 230 |
|
2021
Q2 | $466K | Buy |
924
+167
| +22% | +$84.2K | 0.07% | 256 |
|
2021
Q1 | $346K | Buy |
757
+26
| +4% | +$11.9K | 0.06% | 269 |
|
2020
Q4 | $341K | Buy |
731
+141
| +24% | +$65.8K | 0.08% | 249 |
|
2020
Q3 | $261K | Buy |
+590
| New | +$261K | 0.08% | 251 |
|
2017
Q3 | – | Sell |
-1,581
| Closed | -$276K | – | 337 |
|
2017
Q2 | $276K | Buy |
+1,581
| New | +$276K | 0.09% | 299 |
|